Cell and gene therapy patents: What’s accelerating, what’s lagging behind - Pharmaceutical Technology

Cell and gene therapy patent filings fell 25% to May 2026, while grant ratios rose. Discover IP concentration by disease, assignee and technology. Cell and gene therapy patent filings fell 25% to May 2026, but grant ratios rose to 0.35. Credit: Shutterstock This content is password protected. To view it please enter your password below: The leading site for news and procurement in the pharmaceutical industry

Source: Pharmaceutical Technology